Aventis / Novartis Pharma AG / Malaria Venture / Agency for Food / Sanofi / Sanofi-Aventis / /
Country
Switzerland / Rwanda / Senegal / Niger / Benin / Cambodia / Mozambique / Sweden / South Africa / New Zealand / Kenya / France / Uganda / Burkina Faso / Tanzania / Nigeria / Madagascar / Ghana / /
Event
FDA Phase / /
Facility
Information Centre / University of Otago / Affordable Medicine Facility / University of Ghana Medical School / Uppsala Monitoring Centre / /
IndustryTerm
spontaneous reporting systems / pharmaceutical sector / health infrastructure / particular product / pharmaceutical / similar health infrastructure / /
MedicalCondition
Back Malaria / Roll Back Malaria / disease / malaria / fever / suspected malaria / vomiting / severe malaria / AIDS / Tropical Diseases / Tuberculosis / /
MedicalTreatment
counselling / /
Organization
World Health Organization / Food and Drug Administration / Uppsala Monitoring Centre / Drug Information Department / National Agency / Eduardo Mondlane University Medical School / National Pharmacovigilance Centre / Global Fund / Centre for Tropical Pharmacology and Therapeutics / University of Otago / Information Centre / National Drug Authority / Cosmetics / Tanzania Food and Drugs Authority / University of Ghana Medical School / Ministry of Health / J. Pandit / Pharmacy and Poisons Board / /
Person
S. Schwarte / J. Van Erps / Maud Lugand / H. Hogerzeil / J. Sillah / M. Imai / U. Mehta / A. Bosman / S. Spinaci / M. Couper / /
Microsoft Word - Content.doc